ex dividendGGNeodhd
GGN (GGN) Goes Ex-Dividend Tomorrow
GGN (NYSE:GGN) will go ex-dividend tomorrow, August 17, 2026.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
GGN (NYSE:GGN) will go ex-dividend tomorrow, August 17, 2026.
Read morePetVivo Holdings, Inc. (OTC:PETV) filed a Form 8-K with the Securities and Exchange Commission on August 20, 2026, disclosing a material event.
Read moreGLU (NYSE:GLU) will go ex-dividend tomorrow, August 17, 2026.
Read morePROSPECT CAPITAL CORP (NASDAQ:PSEC) filed its annual report (Form 10-K) with the Securities and Exchange Commission on August 20, 2026.
Read moreGDV (NYSE:GDV) will go ex-dividend tomorrow, August 17, 2026.
Read moreNORDSON CORP (NASDAQ:NDSN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 20, 2026.
Read moreHRZN (NASDAQ:HRZN) will go ex-dividend tomorrow, August 17, 2026.
Read moreCAPITAL ONE FINANCIAL CORP (NYSE:COF) filed a Form 8-K with the Securities and Exchange Commission on August 20, 2026, disclosing a material event.
Read moreSCANSOURCE, INC. (NASDAQ:SCSC) filed its annual report (Form 10-K) with the Securities and Exchange Commission on August 20, 2026.
Read moreUDR (NYSE:UDR) will go ex-dividend tomorrow, August 17, 2026.
Read moreOXSQ (NASDAQ:OXSQ) will go ex-dividend tomorrow, August 17, 2026.
Read morePSMT (NASDAQ:PSMT) will go ex-dividend tomorrow, August 17, 2026.
Read moreBenchmark reiterated its Speculative Buy rating on Unicycive Therapeutics, Inc. (NASDAQ:UNCY) on August 20, 2026.
Read moreUBS reiterated its Neutral rating on Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) on August 20, 2026.
Read moreB. Riley Securities reiterated its Buy rating on Opera Limited (NASDAQ:OPRA) on August 20, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Relay Therapeutics, Inc.
Read moreBarclays analysts initiated coverage on Bitdeer Technologies Group (NASDAQ:BTDR) with a rating of Overweight on August 20, 2026.
Read moreJP Morgan reiterated its Overweight rating on Edgewise Therapeutics, Inc. Common Stock (NASDAQ:EWTX) on August 20, 2026.
Read moreNeedham reiterated its Buy rating on Sezzle Inc. (NASDAQ:SEZL) on August 20, 2026.
Read moreRBC Capital reiterated its Sector Perform rating on MFA Financial, Inc. 8.875% Senior Notes (NYSE:MFAN) on August 20, 2026.
Read more